Theme 5: Psychiatry II. A complete summary of all exam material!
4 views 0 purchase
Course
Oorzaken van ziekten 3.1 (GK03.1)
Institution
Rijksuniversiteit Groningen (RuG)
Upon recommendation of my fellow students, I now sell my summaries! In this summary, I use a lot of images, tables and enumerations. This means you don't have to read long pieces of boring and complicated text. This summary contains all the material of the books, lectures and learning objectives. T...
,Inhoud
Week 17: MUS (medically unexplained symptoms), PPS (persistent physical symptoms) and somatic
symptom disorder..................................................................................................................................4
Introduction........................................................................................................................................7
Somatic symptom and related disorders............................................................................................9
Syndromes......................................................................................................................................9
Development, course and impact.................................................................................................11
Diagnosis.......................................................................................................................................11
Differential diagnosis....................................................................................................................12
Epidemiology................................................................................................................................12
Aetiopathogenesis........................................................................................................................12
Treatment.....................................................................................................................................13
Factitious disorders..........................................................................................................................15
Syndromes....................................................................................................................................15
Development, course and impact.................................................................................................15
Diagnosis.......................................................................................................................................15
Differential diagnosis....................................................................................................................15
Aetiopathogenesis........................................................................................................................16
Treatment.....................................................................................................................................16
Functional neurological disorder......................................................................................................17
History..........................................................................................................................................17
Definition of FND..........................................................................................................................17
Pathophysiology...........................................................................................................................18
Treatment.....................................................................................................................................18
Occupational medicine.....................................................................................................................20
The insurance physician and the assessment of occupational disability......................................20
The absenteeism and occupational disability in social context....................................................20
Week 18: Psychosis..............................................................................................................................22
Psychosis spectrum disorders...........................................................................................................22
Introduction..................................................................................................................................22
Syndromes....................................................................................................................................22
Development, course and impact.................................................................................................26
Diagnosis.......................................................................................................................................27
Differential diagnosis....................................................................................................................27
Epidemiology................................................................................................................................28
Aetiopathogenesis........................................................................................................................28
2
, Treatment.....................................................................................................................................29
Psychiatry and the law......................................................................................................................32
The medical treatment contracts act (WGBO)..............................................................................32
The psychiatric hospitals (Compulsory admission) act (Wet BOPZ)..............................................33
Medicines in psychiatry....................................................................................................................35
Antidepressants............................................................................................................................35
Antipsychotics...............................................................................................................................36
Benzodiazepines...........................................................................................................................37
New pharmaceuticals, like es-ketamine and psylocibin................................................................37
Week 19: Stagnation............................................................................................................................38
Personality disorders........................................................................................................................38
Introduction..................................................................................................................................38
Syndromes....................................................................................................................................38
Development, course and impact.................................................................................................44
Diagnosis.......................................................................................................................................44
Differential diagnosis....................................................................................................................45
Epidemiology................................................................................................................................45
Aetiopathogenesis........................................................................................................................46
Treatment.....................................................................................................................................47
Neurodevelopmental disorders........................................................................................................49
Introduction..................................................................................................................................49
Syndromes....................................................................................................................................49
Development, course and impact.................................................................................................54
Diagnosis.......................................................................................................................................55
Differential diagnosis....................................................................................................................55
Epidemiology................................................................................................................................56
Aetiopathogenesis........................................................................................................................56
Treatment.....................................................................................................................................57
3
, Week 17: MUS (medically unexplained symptoms), PPS
(persistent physical symptoms) and somatic symptom
disorder
MUS = physical symptoms that last for longer than a few weeks and which cannot be
satisfactorily explained after adequate medical examination.
40% of consultations about certain symptoms cannot be explained by a medical condition
MUS = not a specific disease focuses on the symptoms that cause persistent functional
impairment
Steps in treatment:
1. The GP treats the patient
2. The GP works together with or sends the patient to other primary care providers
physiotherapists or psychologists
3. Treatment provided by multidisciplinary teams or treatment centres
After 12-15 months: symptoms improved in 50-75% of patients 10-30% have an increase
in symptoms
A good doctor-patient relationship is important improves prognosis
Relationship is often pressured due to rising frustration
Non-specific symptoms:
Fatigue
Headache
Dizziness
Lack of concentration
Memory problems
Assessment of MUS is based on 5 dimensions: SCEGS
1. Somatic tells the patient that the symptoms and their burden are taken seriously
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller KatieZara. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $5.39. You're not tied to anything after your purchase.
